全文获取类型
收费全文 | 2811篇 |
免费 | 261篇 |
国内免费 | 1篇 |
出版年
2022年 | 26篇 |
2021年 | 48篇 |
2020年 | 18篇 |
2019年 | 36篇 |
2018年 | 38篇 |
2017年 | 40篇 |
2016年 | 68篇 |
2015年 | 81篇 |
2014年 | 133篇 |
2013年 | 120篇 |
2012年 | 177篇 |
2011年 | 155篇 |
2010年 | 111篇 |
2009年 | 93篇 |
2008年 | 147篇 |
2007年 | 156篇 |
2006年 | 141篇 |
2005年 | 143篇 |
2004年 | 145篇 |
2003年 | 131篇 |
2002年 | 136篇 |
2001年 | 79篇 |
2000年 | 105篇 |
1999年 | 73篇 |
1998年 | 35篇 |
1997年 | 42篇 |
1996年 | 39篇 |
1995年 | 46篇 |
1994年 | 33篇 |
1993年 | 35篇 |
1992年 | 47篇 |
1991年 | 38篇 |
1990年 | 38篇 |
1989年 | 25篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 17篇 |
1985年 | 14篇 |
1984年 | 23篇 |
1983年 | 9篇 |
1982年 | 20篇 |
1980年 | 19篇 |
1979年 | 14篇 |
1978年 | 11篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1974年 | 13篇 |
1973年 | 11篇 |
1972年 | 10篇 |
1970年 | 11篇 |
排序方式: 共有3073条查询结果,搜索用时 15 毫秒
941.
Ganassin Maria Julia Mileo García-Berthou Emili Rodrigues Amanda Cantarute do Nascimento Carolina Pedrozo Muniz Carolina Mendes Baumgartner Matheus Tenório Schmitz Marcelo Henrique Gomes Luiz Carlos 《Hydrobiologia》2021,848(9):2189-2201
Hydrobiologia - Using a long time series, we analyzed trends in abundance of two characiform fishes in the upper Paraná River and its floodplain: the native Schizodon altoparanae and its alien... 相似文献
942.
943.
Coronavirus Disease 2019 (COVID-19), a disease caused by the betacoronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has only recently emerged, while Mycobacterium leprae, the etiological agent of leprosy, has endured for more than 2,000 years. As soon as the initial reports of COVID-19 became public, several entities, including the Brazilian Leprosy Society, warned about the possible impact of COVID-19 on leprosy patients. It has been verified that COVID-19 carriers can be either asymptomatic or present varying degrees of severe respiratory failure in association with cytokine storm and death, among other diseases. Severe COVID-19 patients show increased numbers of neutrophils and serum neutrophil extracellular trap (NET) markers, in addition to alterations in the neutrophil-to-lymphocyte ratio (NLR). The absence of antiviral drugs and the speed of COVID-19 transmission have had a major impact on public health systems worldwide, leading to the almost total collapse of many national and local healthcare services. Leprosy, an infectious neurological and dermatological illness, is widely considered to be the most frequent cause of physical disabilities globally. The chronic clinical course of the disease may be interrupted by acute inflammatory episodes, named leprosy reactions. These serious immunological complications, characterized by cytokine storms, are responsible for amplifying peripheral nerve damage. From 30% to 40% of all multibacillary leprosy (MB) patients experience erythema nodosum leprosum (ENL), a neutrophilic immune-mediated condition. ENL patients often present these same COVID-19-like symptoms, including high levels of serum NET markers, altered NLR, and neutrophilia. Moreover, the consequences of a M. leprae–SARS-CoV-2 coinfection have yet to be fully investigated. The goal of the present viewpoint is to describe some of the similarities that may be found between COVID-19 and leprosy disease in the context of neutrophilic biology. 相似文献
944.
In plant cells, DNA is packaged into chromatin by wrapping around histone octamers. Pathways that lead to cytosine DNA methylation, posttranslational histone modifications and certain components of the RNA interfering (RNAi) pathway are critically important in modulating chromatin structure, thereby affecting many molecular processes that take place in a cell. Recent advances in microarray and high-throughput sequencing technologies have made it possible to study these pathways on a genome-wide scale. Results from such epigenomic studies are broadening our understanding of plant genomes and are also providing important clues regarding the mechanisms and functions of these pathways that can be further tested using genetic and biochemical approaches. This review focuses on the high-throughput approaches that have been successfully applied in plant epigenomic studies. 相似文献
945.
946.
Stephen I Rennard Peter MA Calverley Udo M Goehring Dirk Bredenbr?ker Fernando J Martinez 《Respiratory research》2011,12(1):18
Background
As chronic obstructive pulmonary disease (COPD) is a heterogeneous disease it is unlikely that all patients will benefit equally from a given therapy. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, has been shown to improve lung function in moderate and severe COPD but its effect on exacerbations in unselected populations was inconclusive. This led to the question of whether a responsive subset existed that could be investigated further.Methods
The datasets of two previous replicate, randomized, double-blind, placebo-controlled, parallel-group studies (oral roflumilast 500 μg or placebo once daily for 52 weeks) that were inconclusive regarding exacerbations were combined in a post-hoc, pooled analysis to determine whether roflumilast reduced exacerbations in a more precisely defined patient subset.Results
The pooled analysis included 2686 randomized patients. Roflumilast significantly decreased exacerbations by 14.3% compared with placebo (p = 0.026). Features associated with this reduction were: presence of chronic bronchitis with or without emphysema (26.2% decrease, p = 0.001), presence of cough (20.9% decrease, p = 0.006), presence of sputum (17.8% decrease, p = 0.03), and concurrent use of inhaled corticosteroids (ICS; 18.8% decrease, p = 0.014). The incidence of adverse events was similar with roflumilast and placebo (81.5% vs 80.1%), but more patients in the roflumilast group had events assessed as likely or definitely related to the study drug (21.5% vs 8.3%).Conclusions
This post-hoc, pooled analysis showed that roflumilast reduced exacerbation frequency in a subset of COPD patients whose characteristics included chronic bronchitis with/without concurrent ICS. These observations aided the design of subsequent phase 3 studies that prospectively confirmed the reduction in exacerbations with roflumilast treatment.Trials registration
ClinicalTrials.gov identifiers: and NCT00076089. NCT00430729相似文献947.
Barkhudarova F Dähnrich C Rosemann A Schneider U Stöcker W Burmester GR Egerer K Schlumberger W Hiepe F Biesen R 《Arthritis research & therapy》2011,13(1):R20
Introduction
In this study, we sought to determine the diagnostic value and clinical laboratory associations of autoantibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in systemic lupus erythematosus (SLE). 相似文献948.
Jalid Sehouli Christoph Loddenkemper Tatjana Cornu Tim Schwachula Ulrich Hoffmüller Andreas Grützkau Philipp Lohneis Thorsten Dickhaus J?rn Gr?ne Martin Kruschewski Alexander Mustea Ivana Turbachova Udo Baron Sven Olek 《Epigenetics》2011,6(2):236-246
The immune system plays a pivotal role in tumor establishment. However, the role of T-lymphocytes within the tumor microenvironment as major cellular component of the adaptive effector immune response and their counterpart, regulatory T cells (Treg), responsible for suppressive immune modulation, is not completely understood. This is partly due to the lack of reliable technical solutions for specific cell quantification in solid tissues. Previous reports indicated that epigenetic marks of immune cells, such as the Treg specifically demethylated region (TSDR) within the FOXP3 gene, may be exploited as robust analytical tool for Treg-quantification. Here, we expand the concept of epigenetic immunophenotyping to overall T-lymphocytes (oTL). This tool allows cell quantification with at least equivalent precision to FACS and is adoptable for analysis of blood and solid tissues. Based on this method, we analyze the frequency of Treg, oTL and their ratio in independent cohorts of healthy and tumorous ovarian, colorectal and bronchial tissues with 616 partly donor-matched samples. We find a shift of the median ratio of Treg-to-oTL from 3–8% in healthy tissue to 18–25% in all tumor entities. Epigenetically determined oTL frequencies correlate with the outcome of colorectal and ovarian cancers. Together, our data show that the composition of immune cells in tumor microenvironments can be quantitatively assessed by epigenetic measurements. This composition is disturbed in solid tumors, indicating a fundamental mechanism of tumor immune evasion. Epigenetic quantification of T-lymphocytes serves as independent clinical parameter for outcome prognosis.Key words: tumor immunology, regulatory T cells, T-lymphocytes, epigenetic immunophenotyping, DNA methylation 相似文献
949.
Shaheed V. Omar Andreas Roth Nazir A. Ismail Linda Erasmus Marthie Ehlers Marleen Kock Nuraan Paulse Halima M. Said Anwar A. Hoosen Udo Reischl 《PloS one》2011,6(9)
Background
The LightCycler® Mycobacterium Detection Kit based on real-time PCR technology for the detection of Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium kansasii was recently developed. This study evaluated its analytical sensitivity, specificity and reproducibility.Methodology/Principal Findings
Plasmid standards were prepared and used to determine the limit of detection. The assay was also performed against organisms other than mycobacteria, other mycobacterial strains and interfering substances to exclude cross-reactivity and interference. Reference standards were prepared and tested to assess the assay''s reproducibility. All PCR assays were performed using the LightCycler® 2.0 Instrument. The detection limit for M. tuberculosis was 28 copies per microlitre. Neither cross-reactivity nor interference occurred with non-mycobacterial organisms and substances tested. Overall reproducibility for consecutive measurements, run-to-run, lot-to-lot, day-to-day and laboratory-to-laboratory achieved a coefficient of variance of less than two percent.Significance
The LightCycler® Mycobacterium Detection kit has shown to be a robust and accurate assay with the potential to be used as a rapid TB diagnostic test. 相似文献950.